Abstract: Immunogenic peptides containing amino acid residues which define a binding site to a CD4 receptor are disclosed. Antibodies to these peptides are also disclosed. Methods of reducing the ability of a gp120 env protein to bind to CD4 are also disclosed. Methods of treatment and prophylaxis using these antibodies and peptides are also described.
Type:
Grant
Filed:
March 26, 1992
Date of Patent:
October 6, 1998
Assignee:
Dana-Farber Cancer Instistute
Inventors:
Joseph G. Sodroski, William A. Haseltine, Craig D. Furman, Udy Olshevsky, Eirik Helseth, Richard Wyatt, Markus Thali